Results 291 to 300 of about 881,500 (386)

Valvular Heart Disease and a Pregnancy-Associated Death: The Case for Maternal Mortality Review. [PDF]

JACC Case Rep
Bergo C, Kotini-Shah P, Jones RL, Love-Clark A, Masinter L, Briller JE.   +5 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Assessment of aortic and mitral valve regurgitation volumes by cardiovascular magnetic resonance in participants without valvular heart disease in the Hamburg City Health Study population. [PDF]

Int J Cardiovasc Imaging
Riedl KA, Koliopanos G, Albrecht JN, Cavus E, Wenzel JP, Sinn M, Schoennagel BP, Lund GK, Adam G, Kirchhof P, Blankenberg S, Ziegler A, Muellerleile K.   +12 more
europepmc   +1 more source

Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly [PDF]

Dora L. Costa
core  

Chronic Valvular Disease of the Heart: Its Etiology, the Factors Leading to Failure of Compensation, and the Symptoms Produced.

, 1914
David MacDonald
openalex   +1 more source

Valvular Heart Disease in the Elderly Population

, 2003
Windsor Ting, Craig R. Smith
openalex   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey. [PDF]

Eur Heart J
Mascherbauer J, Kammerlander A, Nitsche C, Bax J, Delgado V, Evangelista A, Laroche C, Maggioni AP, Magne J, Vahanian A, Iung B.   +10 more
europepmc   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Current applications and future perspectives of artificial intelligence in valvular heart disease. [PDF]

J Transl Int Med
Jiang L, Zuo H, Wang XJ, Chen C.
europepmc   +1 more source